QualityStocksNewsBreaks Archives - Page 358 of 1423

ThursdayOct 27, 2022 10:44 am

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Names New Auditing Company

Lottery.com (NASDAQ: LTRY), a global technology company committed to deliver trusted gaming solutions whenever and wherever the lottery is played, has selected Yusufali & Associates LLC as its new independent registered public accounting firm. In that role, the company will perform quarterly financial reviews and annual audits for Lottery.com. In addition, the company has also announced the appointment of new independent board members, along with an interim CEO and interim CFO. Representatives of Yusufali and Associates noted that the firm is committed to the efficient and thorough review and audit of Lottery.com’s public filing in a timely manner. A U.S.-based partner-owned, public…

WednesdayOct 26, 2022 3:02 pm

QualityStocksNewsBreaks – Reklaim Ltd.’s (TSX.V: MYID) (OTCQB: MYIDF) Unique Data Platform Positioned to Respond to Privacy Challenges

Reklaim (TSX.V: MYID) (OTCQB: MYIDF) is the destination for consumers to access and reclaim their data. The company appears poised to position itself as the go-to solution for businesses under swelling pressure to find a partner to solve the compliance gap that has arisen from the transformation of consumer privacy regulations as well as how Big Tech has adapted to changing consumer sentiment and legislation. “With the days of cookies and retargeting ads gone, brands are forced to rethink their marketing strategy – and access to consumer-consented data purchased from a compliant supplier with scale is deemed the critical step…

WednesdayOct 26, 2022 2:37 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Stands Distinct from Others in Lidar Sector

Cepton (NASDAQ: CPTN), a world-leading lidar provider, remains committed to making a potentially game-changing technology available in everyday cars, not just luxury vehicles. “The company expects lidar to benefit more consumers as the technology gets rolled out to all cars, making autonomous driving safer for all. Cepton’s partnership with world-leading automotive tier 1 supplier, Koito, a Tokyo-based manufacturer with century-long operations, marks a significant milestone on Cepton’s journey to lidar commercialization,” reads a recent article. “‘We’re working with top 10 global OEMs here in North America and Japan, and their strategies are still very much intact. So, the progress has…

WednesdayOct 26, 2022 2:29 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Show Takes the Spotlight in Houston, Texas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced that its Robot Roadshow will land at EastGroup Properties, 3955 World Houston Pkwy, in Houston, Texas, on Oct. 27, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Houston Roadshow landing will be guided by Knightscope experts, and visitors will be able to interact directly with each of the ASRs and see the Knightscope Security Operations Center (‘KSOC’) user interface in action. Clients, investors and…

WednesdayOct 26, 2022 1:33 pm

QualityStocksNewsBreaks – Odyssey Health Inc.’s (ODYY) PRV-002 Designed to Expedite Return to Work, Play Following Concussive Episode

Odyssey Health (OTC: ODYY), a medical company with a focus in the area of life-saving medical solutions, has developed a fully synthetic, non-naturally occurring neurosteroid known as PRV-002 intended to treat concussion or mild traumatic brain injury (“mTBI”). “Designed to be administered within a few minutes of a concussive episode, PRV-002 induces an intracellular steroid receptor in brain cells, with the stimulation of this receptor activating multiple gene response elements that promote transcription of anti-inflammatories, antioxidants and efflux channels that remove excess fluid and debris. To put it simply, PRV-002 is intended to reduce swelling, oxidative stress and inflammation, and…

WednesdayOct 26, 2022 12:39 pm

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Approval of Second Clinical Trial Site for Phase 1 Study

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has added Rutgers Cancer Institute of New Jersey (“RCINJ”) as a clinical trial site for its phase 1 CycloSam study. RCINJ has been approved to begin enrolling patients into the study, which will evaluate the effectiveness of CycloSam in treating patients with bone cancer. According to the announcement, RCINJ is part of Rutgers Health and is New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, a designation granted to institutions based on scientific leadership, resources and track record of…

WednesdayOct 26, 2022 12:30 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Present at Largest Gathering in Psychedelic Medicine Sector

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that its VP of R&D, James Kuo, M.D. M.B.A, will speak as a panelist at Wonderland: Miami, the largest business gathering in the psychedelic medicine sector. According to the update, Silo Pharma is a sponsor of the three-day event slated to take place Nov. 3-5, 2022, in Miami, Florida. Dr. Kuo will speak on the Mainstream Pharma and Psychedelics panel scheduled for Saturday, Nov. 5, on the Science Main Stage. “It will be an honor to join other industry leaders as…

WednesdayOct 26, 2022 12:04 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Official Start of the Demonstrator US Tour for Its FIVE EV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the beginning of the Mullen FIVE Strikingly Different EV Crossover Tour, which will commence on Oct. 27 in Pasadena, California. Due to overwhelming interest, the tour has been expanded to add new dates of Nov. 1 and 2 at Angel Stadium in Anaheim, California. “When we announced the Pasadena location, we received an overwhelmingly positive response and were completely booked out in a matter of hours. So, we decided to add an additional LA area stop to ensure more people have the opportunity to experience the FIVE,” said…

WednesdayOct 26, 2022 11:31 am

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) Develops Traction Invertor Tech to Electrify EV Systems

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, was featured in a recent EE/Times article. The article takes a close look at power converters, specifically noting that Hillcrest is showing by example the way to decarbonize the energy sector by developing traction inverter technology for electric vehicles (“EVs”) that eliminates switching losses while enabling power applications to leverage higher switching frequencies, produce improved power system performance and reliability, and operate at higher power levels — all without compromising efficiency. The article notes that…

WednesdayOct 26, 2022 11:18 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Support of EB Awareness Week

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced that it is supporting initiatives to raise awareness of epidermolysis bullosa, a group of rare genetic connective tissue disorders. Epidermolysis Bullosa Global Awareness Week is Oct. 25-31, 2022. “In severe cases of epidermolysis bullosa, or EB, the very fragile skin tears easily and forms painful blisters and open wounds that do not heal quickly,” said Alexandra Mancini, SVP of Clinical and Regulatory Affairs for InMed. “EB is a very important but rare disease that does not get the attention it deserves. EB Awareness…

Site Search

Company Search

Category: QualityStocksNewsBreaks